Naito S, Tanaka H, Tanaka S, Oshima K
Arch Int Pharmacodyn Ther. 1981 Jul;252(1):162-9.
Since there is not an established method for selective assay of kallikrein, it is still unsettled whether kallikrein is absorbed from the intestine or not. Kallikrein was injected into the duodenum of rabbits which had been fasted for 24 hr and the concentrations of the drug in the plasma, lymph and cerebrospinal fluid were determined by an enzymatic method using substrate TAME or Peptide-MCA (hereafter, briefly as TAME method or Peptide-MCA method). An unknown substance, which splits the substrate TAME, appeared in the plasma, lymph and cerebrospinal fluid after injection of kallikrein into the rabbit duodenum. In rabbits which underwent pancreatectomy, kallikrein was not absorbed from the intestine and the unknown substance was not detected in any of the plasma, lymph and cerebrospinal fluid.
由于目前尚无用于选择性测定激肽释放酶的既定方法,激肽释放酶是否会从肠道吸收仍未确定。将激肽释放酶注入禁食24小时的兔子十二指肠中,并使用底物TAME或肽-MCA的酶法(以下简称为TAME法或肽-MCA法)测定血浆、淋巴液和脑脊液中该药物的浓度。将激肽释放酶注入兔子十二指肠后,血浆、淋巴液和脑脊液中出现了一种能分解底物TAME的未知物质。在接受胰腺切除术的兔子中,激肽释放酶不会从肠道吸收,并且在血浆、淋巴液和脑脊液中均未检测到该未知物质。